YahooOctober 12, 2026 at 1:15 PM NY15 Days Ago
Biogen Upgraded to Buy at J.P. Morgan. How the Stock Could Rise 28%.
Biogen stock is upgraded to Overweight from Neutral at J.P. Morgan ahead of a slate of data readouts for compelling pipeline candidates.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
